We used in situ autoradiographic ligand binding methods to determine the occurrence and distribution of dopamine D1 and D2 receptor sub-types in the anole lizard, Anolis carolinensis. Both were present and exhibited pharmacological specificity characteristics similar to those described for mammals. However, unlike in mammals where in the neostriatum [outside the nucleus accumbens/olfactory tubercle complex (NA/OT)] these receptors exhibit only slight dorsolateral (D2 high, D1 low) to ventromedial (D1 high, D2 low) gradients that co mingle extensively, in the anole striatum outside the NA/OT there was a striking laminar pattern, with little if any overlap between D2 (high in a dorsal band) and D1 (high ventral to the D2 band) distributions. As D1 receptors are related to the direct and D2 to the indirect basal ganglia (BG) subsystems in mammals, we also determined anole striatal distributions of pre-proenkephalin mRNA, a marker for striatal efferents to the indirect BG subsystem in mammals. Here, too, there was a striking laminar pattern, with pre-proenkephalin mRNA in a band similar to that seen for D2 receptors. The crisp neuroanatomical separation between these classic BG subsystem markers in Anolis striatum make this species attractive for the study of such systems'' functions during behavior.

Keywords:
Basal ganglia, Dopamine, Enkephalin, Anolis
1.
Ackermann, R.F. (1995) Principles of the deoxyglucose autoradiographic method. In Autoradiography and Correlative Imaging (ed. by W.E. Stumpf and H.F. Solomon), Academic Press, New York, N.Y., pp. 403–421.
2.
Albin, R.L., A.B. Young, and J.B. Penney (1989) The functional anatomy of basal ganglia disorders. TINS, 12: 366–375.
3.
Alexander, G.E., M.R. DeLong, and P.L. Strick (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci., 9: 357–381.
4.
Alexander, G.E., and M.D. Crutcher (1989) Functional architecture of basal ganglia circuits: neuronal substrates of parallel processing. TINS, 12: 266–271.
5.
Anderson, K.D., and A. Reiner (1990) The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res. Rev., 15: 251–265.
6.
Anderson, K.D., and A. Reiner (1991) Striatonigral projection neurons: a retrograde labeling study of the percentages that contain substance P or enkephalin in pigeons. J. Comp. Neurol., 303: 658–673.
7.
Araki, T., H. Kato, K. Kogure, K. Shuto, and Y. Ishida (1992) Autoradiographic mapping of neurotransmitter system receptors in mammalian brain. Pharm. Biochem. Behav., 48: 539–542.
8.
Baxter, L.R. (1999) Functional brain imaging and the brain mediation of obsessive-compulsive disorder (OCD). In Neurobiological Foundation of Mental Illness (ed. by D. Charney, E. Nestler, and W. Bunney), Oxford University Press, New York, N.Y., pp. 534–547.
9.
Baxter, L.R., and R.F. Ackermann (1997) Specific brain circuit activation and 5-HT function during ritualistic territorial displaty vs. non-display in the anole lizard, Anolis carolinensis. Soc. Neurosci. Abstr., 23: 744.
10.
Baxter, L.R., R.F. Ackermann, N.R. Swerdlow, A. Brody, S. Saxens, J.M. Schwartz, J.M. Gregoritch, P. Stoessel, and M.E. Phelps (2000) Specific brain system mediation of obsessive-compulsive disorder responsive to either medication or behavior therapy. In Obsessive-Compulsive Disorder; Contemporary Issues in Treatment (ed. by W. Goodman, M. Rudorfer, and J. Maser), Lawrence Erlbaum Associates, Mahwah, N.J., pp. 573–609.
11.
Baxter, L.R., S. Saxena, A.L. Brody, R.F. Ackermann, M. Colgan, J.M. Schwartz, Z. Allen-Martinez, J.M. Fuster, and M.E. Phelps (1996) Brain mediation of obsessive-compulsive disorder symptoms: evidence from functional brain imaging studies in the human and non-human primate. Sem. Clin. Neuropsych., 1: 32–47.
12.
Besson, M.J., A.M. Graybiel, and B. Quinn (1990) Coexpression of neuropeptides in the cat’s striatum: an immunohistchemical study of substance P, dynophin B, and ekephalin. Neuroscience, 39: 33–58.
13.
Camps, M., P.H. Kelly, and J.M. Palacios (1990) Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species. J. Neural Trans., 80: 105–127.
14.
Clark, E.C., and L.R. Baxter (2000) Mammal-like striatal functions in Anolis. I. Distribution of serotonin receptor subtypes, and absence of striosome and matrix organization. Brain Behav. Evol., 56: 235–248.
15.
Dietl, M.M., and J.M. Palacios (1988a) Neurotransmitter receptors in the avian brain. I. Dopamine receptors. Brain Res., 439: 354–359.
16.
Dietl, M.M., and J.M. Palacios (1988b) Receptor autoradiography as a tool for the study of the basal ganglia. J. Rec. Res., 8: 521–532.
17.
Eberle-Wang, K., Z. Mikeladze, K. Uryu, and M.F. Chesselet (1997) Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J. Comp. Neurol., 384: 233–247.
18.
Gerfen, C.R., T.M. Engber, L.C. Mahan, Z. Susel, T.N. Chase, F.J. Monsma, Jr., and D.R. Sibley (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250: 1429–1432.
19.
Hall, H., G. Sedvall, O. Magnusson, J. Kopp, C. Halldin, and L. Farde (1994) Distribution of D1 and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology, 11: 245–256.
20.
Henselmans, J.M.L., and J.C. Stoof (1991) Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum. Brain Res., 566: 1–7.
21.
Henselmans, J.M.L., P.V. Hoogland, and J.C. Stoof (1991) Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats. Brain Res., 566: 8–12.
22.
Hosli, E., and L. Hosli (1986) Binding sites for [3H]dopamine and dopamine-antagonists on cultured astrocytes of rat striatum and spinal cord: an autoradiographic study. Neurosci. Lett., 65: 177–182.
23.
Inglis, W.L., and P. Winn (1995) The pedunculopontine tegmental nucleus: where the striatum meets the reticular formation. Prog. Neurobiol., 47: 1–29.
24.
Insel, T.R. (1988) Obsessive-compulsive disorder: a neuroethological perspective. Psychopharmacol. Bull., 24: 365–369.
25.
Insel, T.R. (1992) Toward a neuroanatomy of obsessive-compulsive disorder. Arch. Gen. Psychiatry, 49: 739–744.
26.
Kita, H., and S.T. Kitai (1987) Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J. Comp. Neurol., 260: 435–452.
27.
Lidow, M.S. (1993) Autoradiographic visualization of domaminergic receptors. In Receptor Autoradiography Principles and Practice (ed. by J. Wharton and J.M. Polak), Oxford University Press, New York, N.Y., pp. 218–236.
28.
MacLean, P.D. (1990) The Triune Brain in Evolution. Plenum Press, New York, N.Y.
29.
Mega, M., and J.L. Cummings (1994) Frontal-subcortical circuits and neuropsychiatric disorders. J. Neuropsych. Clin. Neurosci., 6: 358–370.
30.
Mijnster, M.J., Y. Galis-de Graff, and P. Voorn (1998) Serotonergic regulation of neuropeptide and glutamic acid decarboxylase mRNA levels in the rat striatum and globus pallidus: studies with fluoxetine and DOI. Brain Res. Mol. Brain Res., 54: 64–73.
31.
Murray, A.M., and J.L. Waddington (1989) The induction of grooming and vacuous chewing by a series of selective D1 dopamine receptor agonists: two directions of D1:D2 interaction. Eur. J. Pharm., 160: 377–384.
32.
Nash, S.R., N. Godinot, and M.G. Caron (1993) Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Mol. Pharmacol., 44: 918–925.
33.
Parent, A. (1986) Comparative Neurobiology of the Basal Ganglia. John Wiley & Sons, New York, N.Y.
34.
Parent, A., and L.N. Hazrati (1995a) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev., 20: 91–127.
35.
Parent, A., and L.N. Hazrati (1995b) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev., 20: 128–154.
36.
Parent, A., A. Charara, D. Pinault (1995b) Single striatofugal axons arborizing in both pallidal segments and in the stustantia nigra in primates, Brain Res., 698: 280–284.
37.
Parent, A., P.Y. Cote, and B. Lavoie (1995a) Chemical anatomy of the basal ganglia. Prog. Neurobiol., 46: 131–197.
38.
Rapaport, J.L., and S.P. Wise (1988) Obsessive-compulsive disorder: is it a basal ganglia dysfunction? Psychopharm. Bull., 24: 380–384.
39.
Regidor, J., and L. Poch (1988) Histochemical analysis of the lizard cortex: an acetylcholinesterase, cytochrome oxidase and NADPH-Diaphorase study. In The Forebrain of Reptiles: Current Concepts of Structure and Function (ed. by W.K. Schwerdtfeger and W.J.A.J. Smeets), Karger, Basel, pp. 77–84.
40.
Saudou, F., and R. Hen (1994) 5-hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem. Int., 25: 503–532.
41.
Sidibe, M., and Y. Smith (1996) Differential synaptic innervation of striatofugal neurones projecting the internal or external segments of the globus pallidus by talamic afferents in the squirrel monkey. J. Comp. Neurol., 365: 445– 465.
42.
Smith, Y., and A. Parent (1988) Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res., 453: 353–356.
43.
Sokoloff, L., M. Reivich, C. Kennedy, M.H. Des Rosiers, C.S. Patlak, K.D. Pettigrew, O. Sakurada, and M. Shinohara (1977) The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem., 28: 897–916.
44.
Surmeier, D.J., W. Song, and Z. Yan (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci., 16: 6579–6591.
45.
Swerdlow, N.R., and G.F. Koob (1987) Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav. Brain Sci., 10: 197– 245.
46.
Szele, F.G., R. Artymyshyn, P.B. Molinoff, and M.F. Chesselet (1991) Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histo-chemistry. Anat. Rec., 231: 548–558.
47.
Voogd, J., R. Nieuwenhuys, P.A.M. van Dongen, and H.J. ten Donkelaar (1998) Mammals. In The Central Nervous System of Vertebrates, Vol. III (ed. by R. Nieuwenhuys, H.J. ten Donkelaar, and C. Nicholson), Springer-Verlag, Berlin, pp. 1637–2097.
48.
Waddington, J.L., S.A. Daly, R.P. Downes, A.M. Deveney, P.G. McCauley, and K.M. O’Boyle (1995) Behavioral pharmacology of ‘D1-like’ dopamine receptors: further subtyping, new pharmacological probes and interactions with ‘D2-like’ receptors. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 19: 811–831.
49.
Wharton, J., and J.M. Polak (eds) (1993) Receptor Autoradiography Principles and Practice. Oxford University Press, New York, N.Y.
50.
Yokoyama, C., H. Okamura, T. Nakajima, J. Taguchi, and Y. Ibata (1994) Autoradiographic distribution of [3H]YM-09151-2, a high affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. J. Comp. Neurol., 344: 121–136.
51.
Yoshikawa, K., K. Maruyama, T. Alzawa, and A. Yamamoto (1989) A new species of enkephalin precursor mRNA with a distinct 5¢-untranslated region in haploid germ cells. FEBS Lett., 264: 193–196.
52.
Yung, K.K.L., A.D. Smith, A.I. Levey, and J.P. Bolam (1996) Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: evidence from dopamine receptor and neuropeptide immunostaining. Eur. J. Neurosci., 8: 861–869.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.